Autosomal dominant long QT syndrome (LQT) is an inherited disorder that causes syncope and sudden death from cardiac arrhythmias. In genetic linkage studies ofseven unrelated families we mapped a gene for LQT to the short arm ofchromosome 11 (lp15.5), near the Harvey ras-1 gene (H ras-1 ). To determine if the same locus was responsible for LQT in additional families, we performed linkage studies with DNA markers from this region (H ras-1 and MUC2). Pairwise linkage analyses resulted in logarithm of odds scores of -2.64 and -5.54 for kindreds 1977 and 1756, respectively. To exclude the possibility that rare recombination events might account for these results, we performed multipoint linkage analyses using additional markers from chromosome 1'p'5.5 (tyrosine hydroxylase and D11S860). Multipoint analyses excluded -25.5 centiMorgans of chromosome 11pl5.5 in K1756 and -13 centiMorgans in K1977. These data demonstrate that the LQT gene in these kindreds is not linked to H ras-1 and suggest that mutations in at least two genes can cause LQT. While the identification of locus heterogeneity of LQT will complicate genetic diagnosis, characterization of additional LQT loci will enhance our understanding of this disorder. (J. Clin. Invest. 1993.
Introduction
In the long QT syndromes (LQT),' individuals suffer from syncope and sudden death due to cardiac arrhythmias, specifically torsade de pointes and ventricular fibrillation. Many of these individuals also have prolongation ofthe QT interval and other repolarization abnormalities on electrocardiograms. LQT can be broadly classified on clinical grounds as acquired ties can also cause this disorder.
LQT can be caused by the inheritance of a single gene (2) . Two inherited forms of LQT are clearly defined on phenotypic and genetic grounds. One is inherited as an autosomal recessive trait and is associated with congenital neural deafness (3) . This form of LQT, often referred to as the Jervell Lange-Nielsen syndrome, is rare. The second, more common, heritable form of LQT is an autosomal dominant trait and is often called the Romano-Ward syndrome (4, 5) . Individuals with autosomal dominant LQT have normal hearing and no other obvious phenotypic abnormalities.
Presymptomatic diagnosis ofinherited LQT has been based on family history and electrocardiographic findings. As the QT interval is affected by age, sex, autonomic tone, and heart rate, and varies widely among both affected and unaffected individuals, the diagnosis of LQT in an asymptomatic individual may be difficult (6) . This is a matter of considerable importance as treatment for LQT exists.
To improve our understanding ofthe mechanisms underlying LQT and to facilitate presymptomatic diagnosis ofthis disorder, we have begun to study families with autosomal dominant LQT. In 1991, we reported tight linkage between the LQT phenotype and the Harvey ras-1 (H ras-1) gene in several families ofnorthern European descent (2, 7) . These data confirmed the autosomal dominant inheritance of an LQT gene in seven families and mapped that gene to the short arm of chromosome 11 (1 lp 15.5). The discovery of linked genetic markers also made genetic testing for LQT feasible for some families. To determine if H ras-1 was useful for genetic testing in additional patients, we examined other families with autosomal dominant LQT. In this report, we characterized two new LQT families, one of Polish descent and another of Italian descent, and showed that the gene for LQT in these families was not linked to H ras-1.
Methods
Phenotypic determination. Kindreds 1977 and 1756 were not previously described. Informed consent was obtained from all study participants or their guardians, in accordance with standards established by local institutional review boards. To determine if family members and spouses had evidence of LQT, we obtained historical data and electrocardiograms from each individual before starting drug treatment. One individual (II-1, K1756) was evaluated while being treated with a beta blocker for hypertension. We evaluated the presence of syncope, the number of syncopal episodes, the age at onset of symptoms, and the (2, 7, 8) .
Typing of RFLP markers. Two DNA markers, known to define polymorphisms on chromosome 1 lp15.5 were used: pTBB-2 at the H ras-I locus (9) and pSMUC41 at the MUC2 locus (10) . Genotyping of RFLP markers was performed as previously described (7).
Typing of PCR-based polymorphic markers. Typing of PCR markers was performed as described by Weber and May (11) Al of loading buffer was added to each reaction, samples denatured for 10 min at 94°C and held on ice. A portion (2.5 gl) ofeach sample was separated by electrophoresis on 6% denaturing polyacrylamide gels which were dried and exposed to x-ray film overnight at -70°C. The following simple sequence repeat markers were used in this study: Dl lS860 (12) and tyrosine hydroxylase (TH) (13).
Linkage analysis. To avoid bias all polymorphisms were scored without knowledge of an individual's phenotypic status. The LINKAGE software package was used to perform both pairwise and multipoint linkage analysis. Penetrance was estimated at 0.90, based on previous estimates (2). We assumed a disease gene frequency of 0.001 and that female and male recombination frequencies were equal. Marker order and distance between markers was determined from published genetic maps and our unpublished data (14). (Table I) . Members of this kindred experienced syncope while at rest and both deaths occurred during sleep, one at age 20 (individual 111-5) and the second at age 31 (individual III-9).
All living members of kindreds 1756 and 1977, with the exception of individual II-1 in K1977, were evaluated for symptoms and signs ofLQT. We examined a total of 15 individuals from K 1756 and thirteen individuals from K1977 (Table  I) . As a result, six living members from K1756 were classified as affected, five as unaffected and three as uncertain (Fig. 1) . In K1977, six individuals were classified as affected and three members as unaffected (Fig. 1) .
Locus Heterogeneity ofLong QT Syndrome 801 (Fig.  2, A and B S f ---------- (8) . Misclassification of a few family members could lead to false conclusions about the presence or absence of linkage in a family, so continued conservative phenotypic classification is warranted. The phenotype of affected members of the families described here appears different from that of previously studied families. The incidence of sudden death was -11% for kindred 1756 and 18% for kindred 1977. By contrast, the incidence of sudden death in three large chromosome 1 l-linked families was lower at -4%. The factors that precipitated arrhythmias in these families also differed from families linked to 1 1p15.5. In kindred 1756 symptoms occurred upon awakening and in kindred 1977 symptoms occurred at rest. Two individuals in this family died during sleep. By contrast, in chromosome 11-linked families arrhythmias were frequently precipitated by exercise or anxiety (50%). In future studies it will be of interest to determine the phenotypic consequences of different LQT mutations.
The identification of locus heterogeneity for autosomal dominant LQT will complicate genetic testing for this disorder. Genetic testing in a family is feasible only after LQT has been linked to chromosome 11 markers in that family. It will be difficult, therefore, to use genetic diagnosis in small families.
The mechanism of QT prolongation in LQT is unknown but may involve prolonged action potential duration in individual cardiac myocytes and dispersion of cardiac repolarization, or afterdepolarizations which contribute to the expression of repolarization potentials on the surface ECG. In theory, anything that affects myocellular depolarization and repolarization could cause LQT. As the autonomic nervous system is an important mediator of cardiac repolarization, it has also been hypothesized that genes involved in the development and regulation of autonomic innervation could be involved in this disorder ( 18, 19, 20, 21) . Given the multiple possible mechanisms that could cause LQT, it should not be surprising that two or more different genetic mechanisms may account for this disorder.
